Raymond James Financial Services Advisors »

Crispr Therapeutics shares owned by Raymond James Financial Services Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Raymond James Financial Services Advisors from 13F filings

Historical chart of Raymond James Financial Services Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Raymond James Financial Services Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Raymond James Financial Services Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.5M 39k 62.60
2023-09-30 $1.5M 33k 45.39
2023-06-30 $1.5M 27k 56.14
2023-03-31 $1.3M 29k 45.23
2022-12-31 $1.1M 27k 40.65
2022-09-30 $1.7M 26k 65.33
2022-06-30 $1.3M 21k 60.77
2022-03-31 $1.5M 24k 62.75
2021-12-31 $2.8M 38k 75.78
2021-09-30 $3.3M 30k 111.94
2021-06-30 $3.2M 20k 161.89
2021-03-31 $3.4M 28k 121.84
2020-12-31 $3.3M 22k 153.10
2020-09-30 $1.3M 15k 83.64
2020-06-30 $934k 13k 73.50
2020-03-31 $459k 11k 42.41
2019-12-31 $657k 11k 60.91
2019-09-30 $374k 9.1k 41.04
2019-06-30 $400k 8.5k 47.04
2019-03-31 $264k 7.4k 35.67
2018-12-31 $215k 7.5k 28.62
2018-09-30 $577k 13k 44.34
2018-06-30 $765k 13k 58.78